With Achim Plum's arrival, HTGF is embedding life sciences expertise in its management team, thereby strengthening the importance of this segment. The early-stage investor is already enjoying considerable success in this area. Portfolio companies such as Scirhom (63 million euros) or Tubulis (128 million euros) were able to realize large follow-up rounds this year.
In addition to the life science sector, the HTGF finances startups in the fields of deeptech, industrialtech, climatetech, digitaltech and chemistry. With its team, the investor It supports young companies in all phases of their development toward becoming international market leaders. It invests in the pre-seed and seed phases and can participate significantly in subsequent financing rounds. Across all its funds, the HTGF manages over two billion euros.
As the new Managing Director, Plum brings over twenty years of experience in the life sciences industry and extensive management knowledge. He has expertise in diagnostics, precision medicine, life science tools, and medical technology. His strength lies in combining scientific expertise with strategic business development. His previous professional positions include Epigenomics, Siemens, Curetis, Ares Genetics, Sphingotech, and Infandx. Plum has supported two IPOs and gained insight into the financing prospects of companies at all stages of development. His broad network in the life sciences industry opens up access to diverse partnerships and new opportunities.
On his new task, Achim Plum:
"I'm looking forward to making the shift from entrepreneur to seed investor and supporting the startup ecosystem in Germany in this new role. With respect for the new challenge and great anticipation of working with my fellow management colleagues and the entire HTGF team, I will use my experience and network to continue the success story of the fund and its portfolio companies."
Matthias Koehler, Chairman of the Investor Advisory Board and Ministerial Director in the Federal Ministry for Economic Affairs and Climate Protection, explains:
"We are delighted that Dr. Achim Plum will complement and enrich the HTGF management team with his comprehensive expertise in the life sciences sector as well as in organizational leadership and development. With Dr. Plum's appointment to the management team, the HTGF is continuing its strategy of representing all three investment focus areas – industrial technology, life sciences and chemistry, and digital technology – at the management level. Life sciences are a key area of innovation that is driving both the transformation of our economy and advances in medicine and healthcare. With his expertise and strong network, Dr. Achim Plum will contribute to further expanding the HTGF portfolio, provide valuable impetus for the strategic development of the HTGF, and sustainably strengthen its role as a leading seed investor."
